(Q51491947)

English

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

Alan R. Zinsmeister

8

object named as

A R Zinsmeister

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

Nicholas Talley

1

object named as

N J Talley

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

3

object named as

D Burton

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

author name string

M Camilleri

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

G Thomforde

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

K Koch

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

M J Rucker

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

J Peterson

7

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

D L Earnest

9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

24

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

859-867

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Review article: tegaserod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Serotoninergic neuroenteric modulators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Effect of tegaserod on gut transit in male and female subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Influence of tegaserod on proximal gastric tone and on the perception of gastric distension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Assessment of gastric accommodation: overview and evaluation of current methods.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

The pharmacokinetics of the novel promotile drug, tegaserod, are similar in healthy subjects-male and female, elderly and young

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

A comparison of the gastric and central nervous system effects of two substituted benzamides in normal volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

No effect of cisapride on paracetamol absorption after oral simultaneous administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03049.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.03049.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16918891

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51491947&oldid=2130327449"